| CIT Boxing 华山论剑 |
|||
| Chair 主席 | Runlin Gao 高润霖, Yaling Han 韩雅玲 | ||
| Panelist 评论者 | Bo Xu 徐波, Shaoliang Chen 陈绍良, Jinghua Liu 柳景华, Yu Wang 王禹, Jiyan Chen 陈纪言, Hong Jiang 江洪 | ||
|
1:30 PM- |
Opening Remarks 开场致辞 |
||
|
1:40 PM- |
The benefits of bivalirudin ONLY translate to patients treated with transfemoral PCI 比伐芦定在股动脉入路的PCI病人中有优势 |
Zening Jin 金泽宁 | |
|
1:55 PM- |
The benefits of bivalirudin ALSO translate to patients treated with transradial PCI 比伐芦定在桡动脉入路的PCI病人中有优势 |
Yida Tang 唐熠达 | |
|
2:10 PM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
||
|
2:20 PM- |
Stent thrombosis risk is higher with Bivalirudin in STEMI Procedures 对于STEMI病人使用比伐芦定可能增加支架内血栓发生风险 |
Jian Liu 刘健 | |
|
2:35 PM- |
Stent thrombosis risk is not more common with Bivalirudin than UFH±GPI in STEMI Procedures 对于STEMI病人使用比伐芦定不增加支架内血栓风险 |
Yi Li 李毅 | |
|
2:50 PM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
||
|
3:00 PM- |
Summary& Closing 总结 |
||
| From Guideline to Practice: Case Reviews 从指南到实践：病例讨论 |
|||
| Chair 主席 | Jianhong Tao 陶剑虹, Weijian Huang 黄伟剑, Yundai Chen 陈韵岱, Yuqing Hou 侯玉清, Yuguo Chen 陈玉国 | ||
|
3:10 PM- |
Opening Remarks 开场致辞 |
||
|
3:20 PM- |
The application of Bivalirudin among Specific patients 比伐芦定在特殊病人中的应用 |
Xin Zhao 赵昕 | |
|
3:30 PM- |
The application of Bivalirudin among NSTEMI patients 比伐芦定在NSTEMI病人中的应用 |
Hongwei Pan 潘宏伟 | |
|
3:40 PM- |
The application of Bivalirudin among right coronary artery CTO disease patients 比伐芦定在右冠CTO病人中的应用 |
Qiang Xie 谢强 | |
|
3:50 PM- |
The application of Bivalirudin among elderly female patients 比伐芦定在高龄女性病人中的应用 |
Haiyan Wang 王海燕 | |
|
4:00 PM- |
The application of Bivalirudin among STEMI patients 比伐芦定在STEMI病人中的应用 |
Rixin Xu 徐日新 | |
|
4:10 PM- |
The application of Bivalirudin among high bleeding risk patients 比伐芦定在高出血风险病人中的应用 |
Jing Huang 黄晶 | |
|
4:20 PM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
||
|
4:30 PM- |
Adjourn 休会 |
||